Skip to content
19 November · 06:30 UTCFollow Smith & Nephew by emailFollow

SN · Pharma and healthcare · one day

Smith & Nephew (SN): news on Thursday 19 November 2026

News from the 24 hours to Thursday morning, 19 November 2026.

Tone of the day

−2.0slightly negative
Relevant headlines3of 6 read
Stories3grouped by event

What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.

Why it scored this way

Coverage centred on a guidance cut that sent the shares lower and put the orthopaedics business under scrutiny. That was partly offset by directors buying ADSs and Barclays raising its price target.

What drove it

  • guidance cut
  • director share purchases
  • Barclays price target

Around this day

DayToneHeadlines
Fri 13 Nov−5.73
Sat 14 Nov0.01
Tue 17 Nov+2.02
Wed 18 Nov+4.83
Thu 19 Nov−2.03

3 stories · 3 headlines · strongest first

Pharma and healthcare on 19 NovemberFTSE 100 that day
ToneWhat the article reported, and why it scored that waySource
Smith & Nephew lowers 2026 guidance and ends talks with J&J −4.71 headline today · 24 in all, since 9 October · A piece looks at Smith & Nephew's share slide after the guidance cut and the outlook for its orthopaedics unit.
−9.7Share price fell after the firm lowered its outlook; orthopaedics under scrutiny.Kalkine Media (opens the article) ↗
Barclays raises Smith & Nephew price target to GBP10.40 +7.01 headline today · Barclays lifted its price target on Smith & Nephew to GBP10.40.
+7.0Barclays lifted its price target, signalling analyst optimism on the shares.StreetInsider (opens the article) ↗
Smith & Nephew director share purchases under dividend plan +3.61 headline today · 2 in all, since 13 November · Smith & Nephew disclosed director and PDMR purchases of ADSs.
+5.8Insiders buying American depositary shares shows personal confidence in the business.TipRanks (opens the article) ↗

Each article has its own score. The lines are our own summary; follow the source link to read the article itself.

Follow by email

A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.

How it works. Every morning an AI model reads the UK business news about each FTSE 100 company and scores how good or bad it is for the company, from −10 to +10. Pages update by about 07:45 UK time.

Not investment advice. MarketFrame rates the tone of news coverage. It is general information, not a recommendation to buy or sell anything. The scores are not share-price data or forecasts: a good score doesn't mean a share will rise, and a bad one doesn't mean it will fall.

Data to 06:30 UTC, 19 November · 909 headlines · 82 companiesMade by Adapt Progress Evolve Limited, a UK company · Privacy · Terms · Who we are · RSS · API · llms.txt